On 26/11, in Hanoi, a signing ceremony was organised for the Memorandum of understanding (MoU) on the partnership to fight against antimicrobial resistance in Vietnam 2021 – 2023 on the occasion of the World antibiotic awareness week.
The partnership is between the Medical Service Administration – Vietnam’s Ministry of Health, the British Embassy in Vietnam and the Representative Office of GSK Pte Ltd in Vietnam.
“With the companionship of the UK Government and companies in the health sector such as GSK, the fight against antimicrobial resistance in Vietnam will be approached in a more comprehensive way. Ongoing medical training programs for healthcare professionals and awareness raising support, community education are also planned to improve the effectiveness of fighting against this medical burden”, Associate Professor Luong Ngoc Khue, Director of Medical Service Administration, Deputy Head of Vietnam National Steering Committee for Antimicrobial Resistance - Ministry of Health shared.
Antimicrobial resistance (AMR) is one of the world’s most critical healthcare challenges. It occurs when microorganisms such as bacteria, viruses, fungi and parasites change in ways that render the medications used to cure the infections they cause ineffective, caused by the inappropriate use of medicines, for example using antibiotics for viral infections such as cold or flu, or sharing antibiotics; low-quality medicines, wrong prescriptions and poor infection prevention and control also encourage the development and spread of drug resistance.
AMR is estimated that by 2050, the number of people dying from antimicrobial resistance could reach 10 million. In Vietnam, rates of AMR are among the highest in Asia, causing thousands of deathsannually.
Some of the most frequently occurring CA-RTIs are acute rhinosinusitis (AS), community-acquired pneumonia (CAP), acute exacerbations of chronic bronchitis (AECB)... In addition, there are many factors contributing to the spread of AMR such as overcrowded healthcare facilities, lack of laboratory resources, insufficient trained staff to detect the issue and inappropriate use of antibiotics by patients, pharmacists and doctors.
Through the signing of an MoU on partnership, Vietnam’s Ministry of Health, the British Embassy in Vietnam and the representative office of GSK have pledged to carry out collaborative activities with a common goal to eliminate AMR in Vietnam.
The partnership is expected to cover three areas: support capability-building and medical education for healthcare professionals(e.g. doctors, pharmacists) in AMR and Appropriate Antibiotic Prescribing(AAP) for community-acquired respiratory infections;provide end-to-end healthcare solutions from prevention to treatment and enhance access to world-class antibiotics and vaccines;increase awareness of AMR’s burden and build understanding of appropriate antibiotic use in the community to prevent AMR in the future.
Speaking at the ceremony, British Ambassador to Vietnam Gareth Ward highlighted: “The UK is committed to working with Vietnam on tackling health issues like AMR and we have raised the level of ambition within our strategic partnership agreement. Antimicrobial resistance is becoming a global health crisis and we need to increase our collective efforts to address this challenge in order to secure the health and wellbeing of our future generations.”